Prediction of Protein Crystallization and Diffraction Quality
蛋白质结晶和衍射质量的预测
基本信息
- 批准号:7903338
- 负责人:
- 金额:$ 23.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectBase SequenceBiologicalBiological ProcessCategoriesCellular StructuresCommunitiesCrystallizationCrystallographyDataData DisplayData SetData Storage and RetrievalDatabasesDiseaseEvaluationFailureGelGenomeGoalsHousingImageIndividualInternetLaboratoriesMachine LearningMedicalMeta-AnalysisMethodsMolecular Sieve ChromatographyNucleic AcidsNumerical valueOnline SystemsOutcomePharmaceutical PreparationsPlayPopulationProcessPropertyProteinsProtocols documentationProtozoaResearchRoleSamplingSecureSet proteinSourceStructureTargeted ResearchTechniquesTrainingWorkX-Ray Crystallographybasedata miningdatabase designdesignfundamental researchgel electrophoresisimprovedlight scatteringmeltingphysical propertypredictive modelingprogramsprotein complexprototypepublic health relevancestructural biologystructural genomicssuccessthree dimensional structuretooltwo-dimensionalweb interfaceweb site
项目摘要
DESCRIPTION (provided by applicant): Given the key role that crystallography plays in structural biology, protein crystallization remains a significant bottleneck affecting a broad range of research programs. We developing a data-mining framework, PROSPERO, that can predict crystallization success and crystal diffraction quality based on characterization of specific protein properties available prior to large-scale crystallization trials. This will increase the efficiency and overall success rates of diffraction studies by individual research programs as well as by genome-scale projects. PROSPERO will perform a meta-analysis of many individual predictors based on statistical and machine-learning methods. A key feature of this framework is that it can dynamically re-estimate success/failure rates based on the current contents of the underlying database, and on the set of physical characterization data provided by individual users. The design will be modular, in that we will define a standard set of application interfaces (APIs) for supplying new categories of data to the core data storage, meta-analysis and prediction components. This will allow use of PROSPERO to be tailored to individual research programs, to target-specific physical properties, and to incorporate new physical characterization techniques. Our long-term goal is to grow a user community that will benefit from the continually improving predictions made by a central PROSPERO web server, that will contribute new input modules based on data produced by standard laboratory protocols and apparatus, and will also contribute to the population of the underlying database of results used for prediction.
PUBLIC HEALTH RELEVANCE: X-ray crystallography is a core technique in fundamental research programs that seek to understand disease mechanisms based on the three-dimensional structure of individual proteins, of large multi-protein complexes, and of larger assemblies of proteins and nucleic acids into key components of the cell. It is also a core technique in highly targeted research programs such as the design of new drugs. This work will increase the efficiency and overall success rate of these research programs by ameliorating a key bottleneck, the difficulty of obtaining high-quality crystals of the biological entity being studied.
描述(由申请人提供):鉴于晶体学在结构生物学中的关键作用,蛋白质结晶仍然是影响广泛研究计划的重要瓶颈。我们开发了一个数据挖掘框架,PROSPERO,可以预测结晶成功和晶体衍射质量的基础上,大规模结晶试验之前可用的特定蛋白质特性的表征。这将提高单个研究项目以及基因组规模项目衍射研究的效率和总体成功率。PROSPERO将基于统计和机器学习方法对许多个体预测因子进行荟萃分析。该框架的一个关键特征是,它可以基于底层数据库的当前内容以及个体用户提供的物理表征数据集来动态地重新估计成功/失败率。设计将是模块化的,因为我们将定义一组标准的应用程序接口(API),用于向核心数据存储,元分析和预测组件提供新的数据类别。这将使PROSPERO的使用量身定制的个人研究计划,目标特定的物理特性,并纳入新的物理表征技术。我们的长期目标是发展一个用户社区,该社区将受益于中央PROSPERO网络服务器所做的不断改进的预测,该网络服务器将根据标准实验室协议和仪器产生的数据贡献新的输入模块,并且还将有助于预测所用结果的基础数据库的人口。
公共卫生关系:X射线晶体学是基础研究项目的核心技术,这些项目旨在了解基于单个蛋白质、大型多蛋白质复合物以及蛋白质和核酸组装成细胞关键组分的三维结构的疾病机制。它也是高度针对性的研究项目(如新药设计)的核心技术。这项工作将通过改善一个关键瓶颈,即获得所研究生物实体的高质量晶体的困难,提高这些研究项目的效率和总体成功率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ETHAN A MERRITT其他文献
ETHAN A MERRITT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ETHAN A MERRITT', 18)}}的其他基金
Drug Design Targeting ProRS in Anaerobic Parasites
针对厌氧寄生虫中 ProRS 的药物设计
- 批准号:
9091419 - 财政年份:2015
- 资助金额:
$ 23.17万 - 项目类别:
MEDICAL STRUCTURAL GENOMICS OF PATHOGENIC PROTOZOA
致病原虫的医学结构基因组学
- 批准号:
8362112 - 财政年份:2011
- 资助金额:
$ 23.17万 - 项目类别:
MEDICAL STRUCTURAL GENOMICS OF PATHOGENIC PROTOZOA
致病原虫的医学结构基因组学
- 批准号:
8362415 - 财政年份:2011
- 资助金额:
$ 23.17万 - 项目类别:
Calcium Dependent Protein Kinase 1 as a drug target for T. gondii and C. parvum
钙依赖性蛋白激酶 1 作为弓形虫和微小弯曲菌的药物靶点
- 批准号:
7937610 - 财政年份:2010
- 资助金额:
$ 23.17万 - 项目类别:
Calcium Dependent Protein Kinase 1 as a drug target for T. gondii and C. parvum
钙依赖性蛋白激酶 1 作为弓形虫和微小弯曲菌的药物靶点
- 批准号:
8097594 - 财政年份:2010
- 资助金额:
$ 23.17万 - 项目类别:
Calcium Dependent Protein Kinase 1 as a drug target for T. gondii and C. parvum
钙依赖性蛋白激酶 1 作为弓形虫和微小弯曲菌的药物靶点
- 批准号:
8288293 - 财政年份:2010
- 资助金额:
$ 23.17万 - 项目类别:
Calcium Dependent Protein Kinase 1 as a drug target for T. gondii and C. parvum
钙依赖性蛋白激酶 1 作为弓形虫和微小弯曲菌的药物靶点
- 批准号:
8688133 - 财政年份:2010
- 资助金额:
$ 23.17万 - 项目类别:
Calcium Dependent Protein Kinase 1 as a drug target for T. gondii and C. parvum
钙依赖性蛋白激酶 1 作为弓形虫和微小弯曲菌的药物靶点
- 批准号:
8485534 - 财政年份:2010
- 资助金额:
$ 23.17万 - 项目类别:
MEDICAL STRUCTURAL GENOMICS OF PATHOGENIC PROTOZOA
致病原虫的医学结构基因组学
- 批准号:
8170019 - 财政年份:2010
- 资助金额:
$ 23.17万 - 项目类别:
相似海外基金
Quantum chemical challenge to elucidate the functional mechanism of base sequence specificity deciding removal of the DNA damage
量子化学挑战阐明碱基序列特异性决定去除 DNA 损伤的功能机制
- 批准号:
19K22903 - 财政年份:2019
- 资助金额:
$ 23.17万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Theoretical Study on Relation of Base sequence and Electronic Structures toward Elucidation of Mechanism of DNA Electric Conductivity.
碱基序列与电子结构关系的理论研究,阐明DNA导电机制。
- 批准号:
16K05666 - 财政年份:2016
- 资助金额:
$ 23.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Prediction and control of base sequence recognition ability for nucleic acid binding proteins by using computer experiments.
利用计算机实验预测和控制核酸结合蛋白的碱基序列识别能力。
- 批准号:
14598001 - 财政年份:2002
- 资助金额:
$ 23.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
FLANKING BASE SEQUENCE ON MUTAGENICITY OF 8 OXOGUANINE
8 氧鸟嘌呤致突变性的侧翼碱基序列
- 批准号:
6362773 - 财政年份:2001
- 资助金额:
$ 23.17万 - 项目类别:
FLANKING BASE SEQUENCE ON MUTAGENICITY OF 8 OXOGUANINE
8 氧鸟嘌呤致突变性的侧翼碱基序列
- 批准号:
6137753 - 财政年份:2000
- 资助金额:
$ 23.17万 - 项目类别:
GROWTH HOROMON LOCALIZATION AND ITS BASE SEQUENCE IN BOVINE PANCREATIC
牛胰腺生长激素定位及其碱基序列
- 批准号:
10460134 - 财政年份:1998
- 资助金额:
$ 23.17万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
DNA BASE SEQUENCE EFFECTS IN CHEMICAL CARCINOGENESIS
DNA 碱基序列在化学致癌作用中的作用
- 批准号:
2488608 - 财政年份:1997
- 资助金额:
$ 23.17万 - 项目类别:
DNA BASE SEQUENCE EFFECTS IN CHEMICAL CARCINOGENESIS
DNA 碱基序列在化学致癌作用中的作用
- 批准号:
6475917 - 财政年份:1997
- 资助金额:
$ 23.17万 - 项目类别:
DNA BASE SEQUENCE EFFECTS IN CHEMICAL CARCINOGENESIS
DNA 碱基序列在化学致癌作用中的作用
- 批准号:
6329024 - 财政年份:1997
- 资助金额:
$ 23.17万 - 项目类别:
DNA BASE SEQUENCE EFFECTS IN CHEMICAL CARCINOGENESIS
DNA 碱基序列在化学致癌作用中的作用
- 批准号:
6124462 - 财政年份:1997
- 资助金额:
$ 23.17万 - 项目类别: